BreastArchives
Ligand-functionalized liposomal vesicles in breast cancer: advances in targeted nanotherapeutics
Breast 1 min.
Breast cancer (BC) remains one of the most prevalent malignancies worldwide, characterized by molecular heterogeneity, therapeutic resistance, and high recurrence rates that limit the success of conventional treatments. Although chemotherapy and targeted therapies have improved patient outcomes, their...
Biomarker-driven and AI-assisted nanomedicine for breast cancer: advancing precision drug delivery from bench to bedside
Breast 1 min.
Breast cancer remains the most prevalent malignancy among women worldwide, with its pronounced molecular heterogeneity demanding therapeutic strategies that transcend conventional systemic chemotherapy toward tumor-selective, molecularly precise interventions. The convergence of biomarker science, engineered...
Breast cancer patients' experiences and outcomes of mainstream genetic testing with and without genetic counseling
Breast 1 min.
As demand for breast cancer germline testing has increased, mainstream genetic testing models of care have been implemented to increase access to genetic testing. This study examined patients' experiences of mainstream genetic testing and compared outcomes between patients seen only by their breast specialist...
Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication
Breast 1 min.
This study explored perceptions and initial experiences of abemaciclib, a CDK4/6 inhibitor, plus endocrine therapy (ET) as adjuvant targeted therapy for early breast cancer with high risk of recurrence (EBC). Early onset diarrhea is the most common side-effect, but its impact is often under-recognized...
